{
    "eid": "2-s2.0-85144687758",
    "title": "Immunogenicity, Immune Dynamics, and Subsequent Response to the Booster Dose of Heterologous versus Homologous Prime-Boost Regimens with Adenoviral Vector and mRNA SARS-CoV-2 Vaccine among Liver Transplant Recipients: A Prospective Study",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "heterologous",
        "immunogenicity",
        "liver transplant",
        "SARS-CoV-2",
        "vaccination"
    ],
    "authors": [
        "Supachaya Sriphoosanaphan",
        "Sirinporn Suksawatamnuay",
        "Nunthiya Srisoonthorn",
        "Nipaporn Siripon",
        "Panarat Thaimai",
        "Prooksa Ananchuensook",
        "Kessarin Thanapirom",
        "Bunthoon Nonthasoot",
        "Pokrath Hansasuta",
        "Piyawat Komolmit"
    ],
    "citedby-count": 2,
    "ref-count": 27,
    "ref-list": [
        "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
        "COVID-19 in transplant recipients: The Spanish experience",
        "Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study",
        "Current Take on Systemic Sclerosis Patients\u2019 Vaccination Recommendations",
        "EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients",
        "American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease",
        "Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients",
        "Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients",
        "Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients-A Single-Center Experience",
        "Analysis of antibody responses after COVID-19 vaccination in liver transplant recipients and those with chronic liver diseases",
        "Heterologous prime-boost: Breaking the protective immune response bottleneck of COVID-19 vaccine candidates",
        "Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review",
        "Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): A single-blind, randomised, non-inferiority trial",
        "Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: A prospective cohort study",
        "Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers",
        "Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial",
        "Suggested guidelines for convalescent plasma therapy for the treatment of COVID-19",
        "SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients",
        "Heterologous adenovirus-vector/messenger RNA regimen is associated with improved severe acute respiratory syndrome coronavirus 2 humoral response in liver transplant recipients",
        "Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients",
        "Rapid induction of antigen-specific CD4(+) T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination",
        "Humoral and cellular response of COVID-19 vaccine among solid organ transplant recipients: A systematic review and meta-analysis",
        "Immunogenicity of an mRNA-Based COVID-19 Vaccine among Adolescents with Obesity or Liver Transplants",
        "mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant",
        "Dynamics of Neutralizing Antibody and T-Cell Responses to SARS-CoV-2 and Variants of Concern after Primary Immunization with CoronaVac and Booster with BNT162b2 or ChAdOx1 in Health Care Workers"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Ratchadaphiseksomphot Endowment Fund of Hepatic Fibrosis",
        "Ratchadapiseksompotch Fund",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}